Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ · Healthcare
Xeris Biopharma Holdings, Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 291.8M | 203.1M | 163.9M | 110.2M | 49.6M | 20.2M |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | 24.9M | -33.6M | -44.0M | -81.9M | -115.2M | -83.5M |
| EBITDA | — | — | — | — | — | — |
| Net Income | 554,000 | -54.8M | -62.3M | -94.7M | -122.7M | -91.1M |
| Per Share Data | ||||||
| EPS (diluted) | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 173M | 147M | 138M | 136M | 79M | 60M |
Xeris Biopharma Holdings, Inc. Income Statement — FAQ
Xeris Biopharma Holdings, Inc. (XERS) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XERS's income statement history?
The chart and table above show Xeris Biopharma Holdings, Inc.'s income statement by year and by quarter, including the growth rate.